Sign In
Buy SESN
$0.629
+0 (+0%)
At Close: Jun 06, 2023
San Francisco, California--(Newsfile Corp. - September 1, 2021) - Hagens Berman urges Sesen Bio, Inc. (NASDAQ: SESN) investors with losses in excess of $250,000 to submit your losses now. Class Perio
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sesen Bio, Inc. (SESN)
11:00am, Wednesday, 01'st Sep 2021
LOS ANGELES, Sept. 1, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 18, 2021 deadline to file a lead plaintiff motion in the class action file
Pomerantz Law Firm Announces the Filing of a Class Action Against Sesen Bio, Inc. and Certain Officers - SESN
10:17pm, Tuesday, 31'st Aug 2021
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN) and certain of its offi
DEADLINE: Sesen Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Sesen Bio Class Action Lawsuit - SESN
08:05pm, Tuesday, 31'st Aug 2021
San Diego, California--(Newsfile Corp. - August 31, 2021) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sesen Bio, Inc. (NASDAQ: SESN) securities between December 21, 20
New York, New York--(Newsfile Corp. - August 31, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for th
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
02:00pm, Tuesday, 31'st Aug 2021
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New molecular entity approvals
New York, New York--(Newsfile Corp. - August 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
NEW YORK--(BUSINESS WIRE)--Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company
New York, New York--(Newsfile Corp. - August 30, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sesen Bio, Inc. (NASDAQ: SESN) alleging
NEW YORK, Aug. 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Sesen Bio, I
New York, New York--(Newsfile Corp. - August 29, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
Sesen Update
08:33am, Sunday, 29'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp
Sesen Class Action Reminder
07:43pm, Friday, 27'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp
New York, New York--(Newsfile Corp. - August 27, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sesen Bio, Inc. (NASDAQ: SESN) alleging
